Transdermal and dermal delivery of adefovir: Effects of pH and permeation enhancers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 2, 2008, Pages 597-604

  Vávrová, Kateřina ^a   Lorencová, Kateřina ^a   Klimentová, Jana ^a   Novotný, Jakub ^a   Holý, Antonín ^b   Hrabálek, Alexandr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Acyclic nucleoside phosphonates; Adefovir; Permeation enhancer; Skin absorption; Transdermal drug delivery

Indexed keywords

ADEFOVIR; CARBAMIC ACID DERIVATIVE; LAUROCAPRAM; LAURYL ALCOHOL; PROPIONIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; DRUG TRANSPORT; LIPOPHILICITY; NONHUMAN; PH;

ADENINE; ADMINISTRATION, CUTANEOUS; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; HYDROGEN-ION CONCENTRATION; PERMEABILITY; PHOSPHONIC ACIDS; SKIN ABSORPTION; SOLVENTS;

EID: 43249128108     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.12.005     Document Type: Article

References (37)

1. Danta M., and Dusheiko G. Adefovir dipivoxil: review of a novel acyclic nucleoside analogue. Int. J. Clin. Pract. 58 (2004) 877-886
2. Holy A. Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharm. Des. 9 (2003) 2567-2592
3. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3 (2004) 115-124
4. Thomas B.J., and Finnin B.C. The transdermal revolution. Drug Discov. Today 9 (2004) 697-703
5. Ho E.S., Lin D.C., Mendel D.B., and Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11 (2000) 383-393
6. Benson H.A. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2 (2005) 23-33
7. Smith E.W., and Maibach H.I. Percutaneous Penetration Enhancers (2005), CRC Press p. 448
8. Vávrová K., Zbytovská J., and Hrabálek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr. Med. Chem. 12 (2005) 2273-2291
9. Aspe E., Guy R.H., Lee W.A., Kennedy J.A., Visor G.C., and Ennis R.D. Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog. J. Pharm. Sci. 84 (1995) 750-754
10. Cundy K.C., Shaw J.P., and Lee W.A. Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys. Antimicrob. Agents Chemother. 38 (1994) 365-368
11. Santoyo S., de Jalon E.G., Campanero M.A., and Ygartua P. Determination of cidofovir in both skin layers and percutaneous penetration samples by HPLC. J. Pharm. Biomed. Anal. 29 (2002) 819-826
12. Santoyo S., Ga de Jalon E., Ygartua P., Renedo M.J., and Blanco-Prieto M.J. Optimization of topical cidofovir penetration using microparticles. Int. J. Pharm. 242 (2002) 107-113
13. Vávrová K., Lorencová K., Klimentová J., Novotný J., and Hrabálek A. HPLC method for determination of transdermal and dermal delivery of adefovir (PMEA). J. Chrom. B 853 (2007) 198-203
14. Holy A., and Rosenberg I. Acyclic nucleotide analogs. 3. Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related-compounds. Collect. Czech. Chem. Commun. 52 (1987) 2801-2809
15. Stoughton R.B. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Arch. Dermatol. 118 (1982) 474-477
16. Buyuktimkin S., Buyuktimkin N., and Rytting J.H. Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. Pharm. Res. 10 (1993) 1632-1637
17. Doležal P., Hrabálek A., and Semecký V. Epsilon-aminocaproic acid esters as transdermal penetration enhancing agents. Pharm. Res. 10 (1993) 1015-1019
18. Hrabálek A., Doležal P., Vávrová K., Zbytovská J., Holas T., Klimentová J., and Novotný J. Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin. Pharm. Res. 23 (2006) 912-919
19. Bronaugh R.L., and Maibach H.I. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods. Informa Healthcare (2005) 696
20. Franz T.J. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 64 (1975) 190-195
21. Bronaugh R.L., and Maibach H.I. In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications (1991), CRC Press p. 288
22. Crutcher W., and Maibach H.I. The effect of perfusion rate on in vitro percutaneous penetration. J. Invest. Dermatol. 53 (1969) 264-269
23. Reifenrath W.G., Lee B., Wilson D.R., and Spencer T.S. A comparison of in vitro skin-penetration cells. J. Pharm. Sci. 83 (1994) 1229-1233
24. Kiptoo P.K., Hamad M.O., Crooks P.A., and Stinchcomb A.L. Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion. J. Control. Release 113 (2006) 137-145
25. Kligman A.M., and Christophers E. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 709-712
26. Kopecky Jr. V., Mojzes P., Burda J.V., and Dostal L. Raman spectroscopy study of acid-base and structural properties of 9-[2-(phosphonomethoxy)ethyl]adenine in aqueous solutions. Biopolymers 67 (2002) 285-288
27. J. Levin, H.I. Maibach, Human skin buffering capacity: an overview, Skin Res. Technol, in press, doi:10.1111/j.1600-0846.2007.00271.x.
28. Blindauer C.A., Holy A., Dvorakova H., and Sigel H. Solution properties of antiviral adenine-nucleotide analogues. The acid-base properties of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) and of its N1, N3 and N7 deaza derivatives in aqueous solution. J. Chem. Soc., Perkin Trans. 2 (1997) 2353-2363
29. Wagner H., Kostka K.H., Lehr C.M., and Schaefer U.F. pH profiles in human skin: influence of two in vitro test systems for drug delivery testing. Eur. J. Pharm. Biopharm. 55 (2003) 57-65
30. Holas T., Vávrová K., Ši{dotless}́ma M., Klimentová J., and Hrabálek A. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12. Bioorg. Med. Chem. 14 (2006) 7671-7680
31. Dell'Amico D.B., Calderazzo F., Labella L., Marchetti F., and Pampaloni G. Converting carbon dioxide into carbamato derivatives. Chem. Rev. 103 (2003) 3857-3898
32. Holas T., Zbytovská J., Vávrová K., Berka P., Mádlová M., Klimentová J., and Hrabálek A. Thermotropic phase behavior of long-chain alkylammonium-alkylcarbamates. Thermochim. Acta 441 (2006) 116-123
33. De Clercq E., Holy A., and Rosenberg I. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo. Antimicrob. Agents Chemother. 33 (1989) 185-191
34. Perno C.F., Balestra E., Aquaro S., Panti S., Cenci A., Lazzarino G., Tavazzi B., Di Pierro D., Balzarini J., and Calio R. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. Mol. Pharmacol. 50 (1996) 359-366
35. Reymen D., Naesens L., Balzarini J., Holy A., Dvorakova H., and De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antivir. Res. 28 (1995) 343-357
36. Bendas B., Schmalfuss U., and Neubert R. Influence of propylene glycol as cosolvent on mechanism of drug transport from hydrogels. Int. J. Pharm. 116 (1995) 19-30
37. Heard C.M., and Screen C. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int. J. Pharm. 349 (2008) 323-325